Atherton Lane Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Atherton Lane Advisers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.03M	Sell	9,120 -135	-1%	-$14.7K	0.06%	98
2015 Q3	$936K	Buy	9,255 +45	+0.5%	+$5.4K	0.06%	100
2015 Q2	$1.13M	Sell	9,210 -45	-0.5%	-$5.39K	0.06%	93
2015 Q1	$1.06M	Sell	9,255 -270	-3%	-$29.8K	0.06%	108
2014 Q4	$963K	Sell	9,525 -105	-1%	-$10.2K	0.05%	120
2014 Q3	$878K	Buy	9,630 +1,035	+12%	+$90.8K	0.05%	135
2014 Q2	$736K	Buy	+8,595	New	+$677K	0.04%	153

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Atherton Lane Advisers's IBB Position: Q4 2015 in Review

Atherton Lane Advisers reduced its iShares Biotechnology ETF (IBB) stake by 1.5% in Q4 2015, selling an estimated $14.7K and leaving 9,120 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #98.

Atherton Lane Advisers first reported a position in IBB in Q2 2014 and has held it in 7 quarters since. The position peaked at $1.13M in Q2 2015. 432 funds tracked by Wall St. Rank hold IBB as of Q4 2015.

Atherton Lane Advisers held 9,120 shares of iShares Biotechnology ETF worth $1.03M as of Q4 2015.
Atherton Lane Advisers sold 135 iShares Biotechnology ETF shares in Q4 2015, an estimated $14.7K.
iShares Biotechnology ETF made up 0.06% of Atherton Lane Advisers's portfolio in Q4 2015, its #98 holding.
Atherton Lane Advisers first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 7 quarters since.
Atherton Lane Advisers's iShares Biotechnology ETF position peaked at $1.13M in Q2 2015.
432 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.